Computerized Medical Systems, Inc. Announces PC-based FocalEase Product.

ST. LOUIS--(BUSINESS WIRE)--Oct. 6, 1998--Computerized Medical Systems, Inc. (CMS) announced today the launch of a revolutionary new RTP product called "FocalEase(TM)."

FocalEase is a dedicated contouring workstation application that allows physicians, physicists, and dosimetrists to "segment" or identify critical structures for radiation treatment plans. Users who have seen demonstrations of the product have called it "revolutionary." Dave Vassy, chief physicist at Spartanburg Regional Medical Center, Spartanburg, S.C. stated that "FocalEase will significantly boost efficiency and convenience of defining patient anatomy, especially since it works on existing PCs."

"FocalEase puts the task of identifying tumor volumes and critical structures where it needs to be - on the PC desktop as a client to our market leading FOCUS(R) 3-D RTP system," said Doug Sprague, Chief Executive Officer of CMS. "We are extremely excited by the overwhelming positive reception that demonstrations of this product have received so far. It is the first of a whole family of PC-based products CMS has targeted for improving productivity and clinical efficiency in the radiation oncology department."

CMS has seen strong growth since the management team completed a buyout of the business on March 21, 1997. The total worldwide revenue from sales of CMS products and services for the fiscal year ending March 31, 1998 was $32 Million with domestic revenue growing 25% compared to the previous year. CMS had record first quarter sales for the period ending June 30, 1998. Sales for that period increased 40% over the same period in the previous year. Orders for the second quarter (ending September 30) are also at a record setting pace, with an increase in excess of 185% over the same period in the previous year.

"The board of directors is very pleased with the outstanding growth of the company and the consistent gains in market share. We are especially gratified with the 40% growth in bookings for the first 9 months of this year compared to the previous calendar year. FocalEase will strengthen the company's current leadership position in the marketplace," said Henry Wendt, CMS Chairman of the Board, former chairman of SmithKline Beecham and managing partner of Lighthouse Capital. "The continued excellent performance of the management team, innovation by the development organization and strong financial backing from the investors provides an environment for rapid growth through market expansion and acquisition of additional, vertically oriented companies."

Computerized Medical Systems, Inc. is the worldwide leader in 3-D Radiation Treatment Planning systems. CMS was the first U.S. software manufacturer to achieve ISO-9001 certification. CMS manufactures, markets, and supports the FOCUS 3-D Radiation Treatment Planning Systems, and DynaScan, a Dosimetry system for beam data collection. The CMS headquarters is located in St. Louis, Missouri with regional offices located in Luzern, Switzerland and Hong Kong, Peoples Republic of China.

For further information on CMS, please visit the CMS Website at http://www.cms-stl.com or call CMS at 800/878-4267 or 314/993-0003.